China Traditional Chinese Medicine Holdings Co. Limited
CHIZF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $4 | $8 | $8 | $9 |
| % Growth | -54.1% | -3.1% | -4.9% | – |
| Cost of Goods Sold | $2 | $4 | $4 | $4 |
| Gross Profit | $2 | $4 | $4 | $5 |
| % Margin | 48.7% | 46.7% | 48.4% | 51.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $2 |
| Other Operating Expenses | $0 | $2 | $2 | $2 |
| Operating Expenses | $2 | $4 | $4 | $4 |
| Operating Income | -$0 | -$0 | $0 | $1 |
| % Margin | -0.5% | -0.6% | 4.6% | 7% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | $0 | $1 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$0 | -$0 | $0 | $1 |
| % Margin | -1.4% | -1.9% | 2.5% | 8% |
| EPS | -0.011 | -0.031 | 0.042 | 0.14 |
| % Growth | 65.7% | -174.5% | -70.1% | – |
| EPS Diluted | -0.011 | -0.031 | 0.042 | 0.14 |
| Weighted Avg Shares Out | 5 | 5 | 5 | 5 |
| Weighted Avg Shares Out Dil | 5 | 5 | 5 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | -$0 |
| Interest Expense | $0 | $0 | $0 | -$0 |
| Depreciation & Amortization | $0 | $1 | $1 | $1 |
| EBITDA | $0 | $1 | $1 | $1 |
| % Margin | 9.7% | 7.6% | 10.8% | 12.4% |